| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |